Hospice Care Of Georgia Medicare Approved Location: 9998 Ford Avenue, Suites 4 And 5, Richmond Hill, Georgia 31324 Phone: (864) 542-2100 |
News Archive
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
A genetic search that wound its way from patients to mouse models and back to patients has uncovered an unlikely gene critically involved in a common birth defect which causes mental retardation, motor delays and sometimes autism, providing a new mechanism and potentially improving treatment for the disorder.
In this Kaiser Health News video, Washington Post staff writers, David Hilzenrath, Amy Goldstein, Ceci Connolly, Alec MacGillis and David Brown, also contributors to the Post's new book, Landmark: The Inside Story Of America's New Health Care Law And What It Means For Us All, discuss the new health care law and its implications.
A study published today in the scientific journal Addiction shows that the Mexican government's recent efforts to control the manufacture of methamphetamine have caused a drop in methamphetamine treatment admissions in Mexico and in neighbouring Texas.
AVEO Pharmaceuticals, Inc., today announced data from the final analysis of its Phase 2 randomized discontinuation trial evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with advanced renal cell carcinoma.
› Verified 1 days ago